FDA approves Auvelity for advertising related to Alzheimer’s disease

WEDNESDAY, May 6, 2026 (NewsDay News) — The US Food and Drug Administration has approved the expanded use of Auvelity tablets (dextromethorphan hydrobromide and bupropion hydrochloride) to treat adults with dementia-related agitation from Alzheimer’s disease. Auvelity was originally approved in…












